BFC Planning’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
BFC Planning's AUPH Position: Q3 2026 in Review
BFC Planning reduced its Aurinia Pharmaceuticals (AUPH) stake by 13% in Q3 2026, selling an estimated $1.1K and leaving 450 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.
BFC Planning first reported a position in AUPH in Q3 2024 and has held it in 9 quarters since. The position peaked at $24K in Q4 2025. 214 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- BFC Planning held 450 shares of Aurinia Pharmaceuticals worth $7.29K as of Q3 2026.
- BFC Planning sold 69 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $1.1K.
- Aurinia Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2528 holding.
- BFC Planning first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Aurinia Pharmaceuticals position peaked at $24K in Q4 2025.
- 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.